BiotechTube

Gadobutrol (Gadovist, BAY86-4875)

Phase 3Completed
0 views this week 0 watching💤 Quiet
Interest: 37/100
37
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Carotid Stenosis

Conditions

Carotid Stenosis

Trial Timeline

May 12, 2011 → May 28, 2014

NCT ID
NCT01344447

About Gadobutrol (Gadovist, BAY86-4875)

Gadobutrol (Gadovist, BAY86-4875) is a phase 3 stage product being developed by Bayer for Carotid Stenosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01344447. Target conditions include Carotid Stenosis.

What happened to similar drugs?

3 of 5 similar drugs in Carotid Stenosis were approved

Approved (3) Terminated (1) Active (1)
✅Rosuvastatin (5mg，10mg，20mg) + Rosuvastatin 5mgAstraZenecaApproved
✅Niacin/simvastatin compared to simvastatin alone at 2 dosesMerckApproved
✅EvolocumabAmgenApproved
🔄RosuvastatinAstraZenecaPhase 3
❌Rimonabant + Placebo (for Rimonabant)SanofiPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (7)

NCT IDPhaseStatus
NCT01660841Phase 3Completed
NCT01344447Phase 3Completed
NCT01344460Phase 3Completed
NCT01095081Pre-clinicalCompleted
NCT00905879Pre-clinicalCompleted
NCT00874640Pre-clinicalCompleted
NCT00828737ApprovedCompleted

Competing Products

9 competing products in Carotid Stenosis

See all competitors
ProductCompanyStageHype Score
AbciximabEli LillyPhase 1/2
24
RosuvastatinAstraZenecaPhase 3
40
Rosuvastatin (5mg，10mg，20mg) + Rosuvastatin 5mgAstraZenecaApproved
39
Niacin/simvastatin compared to simvastatin alone at 2 dosesMerckApproved
43
simvastatin + placeboMerckPre-clinical
26
Atorvastatin/niacin extended-release + Atorvastatin + Simvastatin + SimvastatinMerckPhase 2
35
EvolocumabAmgenApproved
39
Atorvastatin - Cholestyramine - SitosterolPfizerPre-clinical
26
Rimonabant + Placebo (for Rimonabant)SanofiPhase 3
32